Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media.

PubWeight™: 7.65‹?› | Rank: Top 0.1%

🔗 View Article (PMID 4370727)

Published in J Infect Dis on November 01, 1974

Authors

L B Reller, F D Schoenknecht, M A Kenny, J C Sherris

Articles citing this

Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother (1982) 3.84

GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae. Antimicrob Agents Chemother (1980) 3.61

Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. Antimicrob Agents Chemother (1975) 3.32

In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. Antimicrob Agents Chemother (1976) 2.75

Acute otitis externa in divers working in the North Sea: a microbiological survey of seven saturation dives. J Hyg (Lond) (1977) 2.56

Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1978) 2.23

Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. Antimicrob Agents Chemother (1979) 2.21

In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria. Antimicrob Agents Chemother (1985) 2.13

Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother (1977) 2.09

Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin. Antimicrob Agents Chemother (1980) 2.01

Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother (1979) 1.86

Susceptibility of lipopolysaccharide-defective mutants of Pseudomonas aeruginosa strain PAO to dyes, detergents, and antibiotics. Antimicrob Agents Chemother (1978) 1.73

Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards. Antimicrob Agents Chemother (1977) 1.72

Quantitative susceptibility test methods in major United States medical centers. Antimicrob Agents Chemother (1981) 1.70

Effect of divalent cation concentrations on the antibiotic susceptibilities of nonfermenters other than Pseudomonas aeruginosa. Antimicrob Agents Chemother (1979) 1.69

Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new). Antimicrob Agents Chemother (1980) 1.62

Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Antimicrob Agents Chemother (1989) 1.61

Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum. Antimicrob Agents Chemother (1980) 1.54

Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories. J Clin Microbiol (1981) 1.44

Activity of gentamicin, tobramycin, polymyxin B, and colistimethate in mouse protection tests with Pseudomonas aeruginosa. Antimicrob Agents Chemother (1975) 1.41

Antibiotic susceptibility of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother (1978) 1.38

Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae. Antimicrob Agents Chemother (1976) 1.36

Rapid determination of minimum inhibitory concentrations of antimicrobial agents by regression analysis of light scattering data. Antimicrob Agents Chemother (1980) 1.33

Broth microdilution testing of Pseudomonas aeruginosa and aminoglycosides: need for employing dilutions differing by small arithmetic increments. J Clin Microbiol (1982) 1.31

Distribution of Pseudomonas aeruginosa in a riverine ecosystem. Appl Environ Microbiol (1983) 1.28

Influence of zinc on Pseudomonas aeruginosa susceptibilities to imipenem. J Clin Microbiol (1993) 1.28

Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother (1987) 1.26

Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. J Clin Microbiol (1980) 1.24

In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae. Antimicrob Agents Chemother (1979) 1.24

Evaluation of a commercial microdilution system for quantitative susceptibility testing of aminoglycosides against multidrug-resistant, gram-negative bacilli. Antimicrob Agents Chemother (1980) 1.23

Sisomicin versus netilmicin: in vitro susceptibility testing. Antimicrob Agents Chemother (1976) 1.21

Macromolecular mechanisms of sputum inhibition of tobramycin activity. Antimicrob Agents Chemother (1995) 1.19

Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa. J Clin Microbiol (1992) 1.16

Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin. J Clin Microbiol (1984) 1.15

Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures. J Clin Microbiol (1989) 1.11

Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5. Appl Environ Microbiol (2005) 1.08

Aminoglycoside resistance among blood culture isolates. J Clin Microbiol (1984) 1.05

Selection of a reference lot of Mueller-Hinton agar. J Clin Microbiol (1986) 1.04

Relationship between gentamicin susceptiblity criteria and therapeutic serum levels for Pseudomonas aeruginosa in mouse infection model. Antimicrob Agents Chemother (1978) 1.02

Antimicrobial agent therapy for Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 1.02

Effect of ionized calcium and soluble magnesium on the predictability of the performance of Mueller-Hinton agar susceptibility testing of Pseudomonas aeruginosa with gentamicin. Antimicrob Agents Chemother (1981) 1.01

Experimental keratitis due to Pseudomonas aeruginosa: model for evaluation of antimicrobial drugs. Antimicrob Agents Chemother (1975) 1.01

Experimental Pseudomonas keratitis. Trans Am Ophthalmol Soc (1981) 1.00

Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. J Clin Microbiol (1992) 0.96

Hospital Pseudomonas aeruginosa: surveillance of resistance to gentamicin and transfer of aminoglycoside R factor. Antimicrob Agents Chemother (1975) 0.96

Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test. Antimicrob Agents Chemother (1983) 0.90

Chemically defined antimicrobial susceptibility test medium for Pseudomonas aeruginosa. Antimicrob Agents Chemother (1977) 0.88

Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram. Antimicrob Agents Chemother (1988) 0.85

Effect of calcium, magnesium, and zinc on ticarcillin and tobramycin alone and in combination against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 0.85

Ability of National Committee for Clinical Laboratory Standards-recommended quality control strains from the American Type Culture Collection to detect errors in disk diffusion susceptibility tests. J Clin Microbiol (1991) 0.85

Five-hour minimal inhibitory concentration test of four antimicrobial agents for Pseudomonas aeruginosa. Antimicrob Agents Chemother (1977) 0.83

Mechanism of uptake of deglucoteicoplanin amide derivatives across outer membranes of Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1993) 0.83

Effects of erythromycin in combination with penicillin, ampicillin, or gentamicin on the growth of Listeria monocytogenes. Antimicrob Agents Chemother (1982) 0.82

Evaluation of Mueller-Hinton agar for disk diffusion susceptibility tests. J Clin Microbiol (1983) 0.80

Chemically defined medium for susceptibility testing of antimicrobial agents. Antimicrob Agents Chemother (1976) 0.79

John C. Sherris, M.D. J Clin Microbiol (2012) 0.78

Effect of manganese in test media on in vitro susceptibility of Enterobacteriaceae and Acinetobacter baumannii to tigecycline. J Clin Microbiol (2012) 0.78

Effect of NaCl supplementation of Mueller-Hinton broth on susceptibility of staphylococci to aminoglycosides. Antimicrob Agents Chemother (1986) 0.77

Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards. Clin Microbiol Rev (1991) 0.75

Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas. Antimicrob Agents Chemother (1988) 0.75

L. Barth Reller, M.D. J Clin Microbiol (2012) 0.75

Totally synthetic medium for susceptibility testing. Antimicrob Agents Chemother (1978) 0.75

Comparison of the Sceptor Pseudomonas Plus MIC Panel with agar dilution for susceptibility testing of Pseudomonas aeruginosa. J Clin Microbiol (1992) 0.75

Activities of four aminoglycosides at subbactericidal concentrations. Antimicrob Agents Chemother (1982) 0.75

Feasibility study of disk diffusion susceptibility tests with Mueller-Hinton broth solidified with Gelrite, an agar substitute. J Clin Microbiol (1985) 0.75

Articles by these authors

Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00

Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 40.37

Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12

Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90

The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis (1983) 10.03

The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol (1981) 8.49

Comparative study of the efficacy of seven paper-reagent strips and conventional biochemical tests in identifying gram-negative organisms. Appl Microbiol (1969) 8.23

Campylobacter enteritis. N Engl J Med (1981) 7.98

Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance. Antimicrob Agents Chemother (1976) 6.86

Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. J Clin Microbiol (1982) 6.19

Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study. J Clin Microbiol (1980) 5.99

Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother (1983) 5.10

Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. J Clin Microbiol (1992) 5.09

Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. Lancet (1999) 4.64

The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis (1983) 4.52

Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49

BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol (1990) 4.35

Neonatal Escherichia coli septicemia--bacterial counts in blood. J Pediatr (1974) 4.18

Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00

Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl Microbiol (1972) 3.55

Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia. J Clin Microbiol (1995) 3.51

Methods and significance of in vitro testing of bacterial sensitivity to drugs. Am J Med (1965) 3.50

Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.44

Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15

Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11

Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol (1993) 2.85

Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis (1998) 2.81

Comparison of acridine orange and Gram stains for detection of microorganisms in cerebrospinal fluid and other clinical specimens. J Clin Microbiol (1981) 2.77

Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol (1994) 2.77

Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62

Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia. J Clin Microbiol (1997) 2.54

Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. J Clin Microbiol (1993) 2.49

Helicobacter nemestrinae sp. nov., a spiral bacterium found in the stomach of a pigtailed macaque (Macaca nemestrina) Int J Syst Bacteriol (1991) 2.37

Bactericidal antibody after colonization with Neisseria meningitidis. J Infect Dis (1973) 2.35

Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol (1994) 2.32

Comparison of acridine orange, methylene blue, and Gram stains for blood cultures. J Clin Microbiol (1982) 2.30

Subgingival microflora and periodontitis. J Periodontal Res (1976) 2.30

A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J Infect Dis (2000) 2.29

Effect of agitation and terminal subcultures on yield and speed of detection of the Oxoid Signal blood culture system versus the BACTEC radiometric system. J Clin Microbiol (1989) 2.25

Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates. J Antimicrob Chemother (1982) 2.25

Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol (2001) 2.23

Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1978) 2.23

Controlled evaluation of BacT/alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia. J Clin Microbiol (1995) 2.21

Restriction enzyme analysis of plasmid DNA and bacteriophage typing of paired Staphylococcus aureus blood culture isolates. J Clin Microbiol (1989) 2.18

Clinical microbiology in developing countries. Emerg Infect Dis (2001) 2.18

Clinical impact of bacteria and fungi recovered only from broth cultures. J Clin Microbiol (1995) 2.17

Laboratory determination of antibiotic susceptibility to ampicillin and cephalothin. Ann N Y Acad Sci (1967) 2.12

In vitro response of Enterobacter to ampicillin. Antimicrob Agents Chemother (1979) 2.06

Diagnostic utility of postmortem blood cultures. Arch Pathol Lab Med (1993) 2.06

Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens. J Clin Microbiol (1981) 2.06

Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04

Application of rejection criteria for stool ovum and parasite examinations. J Clin Microbiol (1992) 2.04

Evaluation of preservative fluid for urine collected for culture. J Clin Microbiol (1979) 2.03

Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin. Antimicrob Agents Chemother (1980) 2.01

Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98

Use of a sodium polyanetholesulfonate disk for the identification of Gardnerella vaginalis. J Clin Microbiol (1985) 1.97

Reliability of cord formation in BACTEC media for presumptive identification of mycobacteria. J Clin Microbiol (1993) 1.94

Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92

Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 1.92

Rejection criteria for endotracheal aspirates from adults. J Clin Microbiol (1993) 1.91

Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. Diagn Microbiol Infect Dis (1993) 1.83

Controlled comparison of original vented aerobic fan medium with new nonvented BacT/ALERT FA medium for culturing blood. J Clin Microbiol (2001) 1.81

Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth. J Clin Microbiol (1982) 1.81

Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med (1983) 1.79

Rationale for selective use of anaerobic blood cultures. J Clin Microbiol (1993) 1.77

Nitrocellulose filter blots for species identification of Mobiluncus curtisii and Mobiluncus mulieris. J Clin Microbiol (1984) 1.75

Stability of antibiotics and chemotherapeutics in agar plates. Appl Microbiol (1970) 1.75

Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis (1982) 1.74

Enriched brucella medium for storage and transport of cultures of Campylobacter fetus subsp. jejuni. J Clin Microbiol (1980) 1.73

Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe. J Infect Dis (1988) 1.72

Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards. Antimicrob Agents Chemother (1977) 1.72

The clinical significance of Aeromonas hydrophila. Report of two cases. Arch Intern Med (1966) 1.72

Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 1.71

Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet (1982) 1.68

Clinical importance of identifying coagulase-negative staphylococci isolated from blood cultures: evaluation of MicroScan Rapid and Dried Overnight Gram-Positive panels versus a conventional reference method. J Clin Microbiol (1998) 1.68

Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67

Comparison of gram stain, DNA probe, and culture for the identification of species of Mobiluncus in female genital specimens. J Infect Dis (1985) 1.66

Bacteriology of dental abscesses of endodontic origin. J Clin Microbiol (1983) 1.65

Relationship of early readings of minimal inhibitory concentrations to the results of overnight tests. Antimicrob Agents Chemother (1975) 1.65

Cryptosporidium, enterocytozoon, and cyclospora infections in pediatric and adult patients with diarrhea in Tanzania. Clin Infect Dis (1999) 1.64

Bacterial endocarditis caused by Oerskovia turbata. Ann Intern Med (1975) 1.61

Decreased incidence of antibiotic resistance among Staphylococcus aureus. A study in a university hospital over a 9-year period. Ann Intern Med (1968) 1.60

Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J Clin Microbiol (2005) 1.60

Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients >/=15 years old, Bangkok. J Infect Dis (1999) 1.60

Duration of incubation of fungal cultures. J Clin Microbiol (1996) 1.60

Rapid determination of minimum inhibitory concentrations of antimicrobial agents by the Autobac method: a collaborative study. Antimicrob Agents Chemother (1980) 1.59

Influence of different media and bloods on results of diffusion antibiotic susceptibility tests. Antimicrob Agents Chemother (1972) 1.59

Controlled evaluation of supplemented peptone and Bactec blood culture broths for the detection of bacteremia and fungemia. J Clin Microbiol (1985) 1.58

Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob Agents Chemother (2001) 1.58

Instability of antibiotic resistance in a strain of Staphylococcus epidermidis isolated from an outbreak of prosthetic valve endocarditis. J Infect Dis (1985) 1.56

Seasonal variation in the etiology of bloodstream infections in a febrile inpatient population in a developing country. Int J Infect Dis (2001) 1.56

Comparative evaluation of Oxoid Signal and BACTEC radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1988) 1.55

Comparison of direct and standard antimicrobial disk susceptibility testing for bacteria isolated from blood. J Clin Microbiol (1979) 1.54